About BBV Review

Advertisement

Abstract

BBVReview.com (Blood Borne Virus Review) is the principal site for accurate, independent information and supportive materials for the diagnosis, care and treatment of blood borne viruses, with a primary focus on Liver Virology (Hepatitis C Virus & Hepatitis B Virus) and HIV. Our target audience is all Healthcare Professionals (HCPs) /private and public sectors/ primary care staff including GPs and specialists, students, researchers, laboratorians, academics, national health authorities and payors.

BBVReview.com provides concise, timely and thorough clinical information and associated educational content aimed at improving patient outcomes. The clinical information provided in BBVReview.com is in the form of review articles, original content, publication of unique and novel clinical data, as well as live and archived streaming video and other media tools.

BBVReview.com has gathered an impressive list of contributors, consisting of highly regarded leaders in the Blood-Borne pathogen field (HIV, HCV and HBV, as well as key global thought leaders to help drive the content and ensure a very high quality product. These include  global thought leaders such as Dr. Mark Thursz, Dr Jean-Michel Pawlotsky, Dr Jürgen Rockstroh, Dr Jordan Feld, Dr. Antonio Craxi, Dr. Graham Foster, Dr. Peter Karayiannis, Dr. Sven Britton, Dr. Nikki Pai, Dr. Mark Nelson, Dr. Rosanna Peeling and Dr. Brian Gazzard.

This world-class team will ensure that we compile a thorough compendium of relevant clinical information and data and help to create a unique user experience. We have augmented this best -in -class medical staff with key individuals from both the private and public sectors. These includes pharmaceutical, medical diagnostics, not-for-profit organisations as well as medical informatics specialists. All hese resources have been assembled to provide a true “patient centric” experience for the end user.

Status

The care and treatment of liver virology (Hepatitis C and Hepatitis B) are undergoing a significant change. With the imminent availability of potent and potentially curative, reasonably patient friendly and interferon-free treatment for Hepatitis C, the need for reliable and timely diagnostic and care clinical information has never been greater. There currently exists a significant un-met need for a reliable and extant source of clinical information for the diagnosis and treatment of blood-borne viruses/infections (BBV).

BBVReview.com will be a site where such information is readily available. The information will cover mono-infected liver virology and HIV, the co-infected HCV/HBV patient, co-infected HIV/HCV and the HIV/HBV co-infected patient.

Objective

BBVReview.com is committed to the provision of thorough, accurate information on the diagnosis, treatment and care of patients with blood borne virus infections.

The audience for BBVReview.com is all HCPs (private and public sectors), students, researchers, laboratorians, academics, national health authorities and payors.

Solution

BBVReview.com will work collaboratively with pharmaceutical and medical diagnostic/device companies to create a powerful, un-branded influential data repository. 

BBVReview.com will deploy innovative tools such as video streaming, mobile apps and other technology to ensure a superior user experience, while accurately communicating information on diagnosis, therapeutics and patient care.

BBVReview.com will utilize state-of-the –art flexible platforms.

Additionally, BBVReview.com will serve as a site for the publication of new papers and articles on the basic biology and epidemiology of blood-borne pathogens.

BBVReview.com is user friendly, visually attractive with a primary focus on quality of content  to give a good user experience.

Summary

BBVReview.com is the principal site for accurate, independent information and supportive materials for the diagnosis, care and treatment of blood borne viruses focusing primarily on Liver Virology (Hepatitis C Virus & Hepatitis B Virus) and HIV.

BBVReview.com has gathered an impressive list of contributors, consisting of highly regarded experts in the blood-borne pathogen field (HIV, HCV and HBV), as well as key global thought leaders to drive the content and ensure a high quality product.

BBVReview.com will collaborate with pharmaceutical and medical diagnostic/device companies to create a powerful, un-branded influential data repository. 

BBVReview.com target audience is specialist health care practitioners, primary care clinicians, allied health specialists, laboratorians, students,  private payers and government health agency employees.

BBVReview.com focus is on the developed world, as well as emerging markets.

Twitter Updates

BBV Review RT @HenryEChang: Sustainable Development Goals for HBV elimination in South Africa: challenges, progress & the road ahead→https://t.co/TCu…
Wednesday, 22 May 2019 09:04
BBV Review RT @grahamscooke: Two helpful pieces on HCV reinfection from @GregDore2 @ProfJohnDillon at a time when we're trying to get access to retrea…
Sunday, 05 May 2019 13:34
BBV Review RT @HenryEChang: Biological basis for functional cure of chronic hepatitis B→https://t.co/vGzHbrJkbs via Drs. MG Martinez, Barbara Testoni…
Sunday, 05 May 2019 13:33
BBV Review RT @HenryEChang: Prevalence, incidence, & outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review & meta-anal…
Sunday, 05 May 2019 13:31